Activation of cytotoxic T lymphocytes requires at least two spleen cell-derived helper factors besides interleukin 2
- PMID: 6220085
Activation of cytotoxic T lymphocytes requires at least two spleen cell-derived helper factors besides interleukin 2
Abstract
The dependency of induction of T cell cytotoxicity on lymphokines was studied. 1 X 10(5) nylon wool-purified thymic lymphocytes or 10(4) spleen cells were cultured with TNP-haptenated syngeneic UV-irradiated spleen cells in the presence of a variety of lymphokine preparations. Concanavalin A-induced spleen cell supernatants mediated strong cytotoxic responses in this system. Three other preparations, namely, a partially purified IL 2 preparation from PMA-stimulated EL-4 thymoma cells, a Con A-induced spleen cell supernatant that was absorbed with an IL 2-dependent cell line, and a Con A-induced supernatant that was dialyzed at pH 2 were all ineffective in mediating a cytotoxic response. In reconstitution experiments, cytotoxic responses were only obtained when either the absorbed preparation or the pH 2-treated preparation was mixed with the IL 2 preparation from EL-4 cells. No reconstitution occurred after mixing of the absorbed with the pH 2-treated preparation. pH 2 treatment of the absorbed preparation did not abolish its synergistic effect when added to the IL 2 preparation from EL-4 cells. These results led to the conclusion that activation of cytotoxic lymphocyte precursors requires at least two other lymphokines in addition to IL 2. One T cell cytotoxicity-inducing factor (TCF1) remained in Con A-induced supernatants after absorption with IL 2 receptor-bearing T cell line cells. It was pH 2-resistant and was not found in EL-4 supernatants. A second T cell cytotoxicity-inducing factor (TCF2) was pH 2-sensitive and was found in Con A-induced spleen cell supernatants as well as in interferon-free supernatants of PMA-stimulated EL-4 cells. This activity co-purified with IL 2. It was absorbed by the IL 2-dependent T cell line together with IL 2. IL 2 differs from TCF2 since it is pH 2-resistant.
Similar articles
-
Capacity of different cell types to stimulate cytotoxic T lymphocyte precursor cells in the presence of interleukin 2.J Immunol. 1984 Jun;132(6):2749-59. J Immunol. 1984. PMID: 6233360
-
Generation of alloreactive cytotoxic T lymphocytes: evidence for a differentiation factor distinct from IL 2.J Immunol. 1983 Feb;130(2):763-7. J Immunol. 1983. PMID: 6600253
-
Activation of nonspecific killer cells by interleukin 2-containing supernatants.J Immunol. 1983 Oct;131(4):1827-33. J Immunol. 1983. PMID: 6194216
-
Cytotoxic T lymphocytes, interleukin-2 and trophoblast involvement.Contrib Gynecol Obstet. 1985;14:23-35. Contrib Gynecol Obstet. 1985. PMID: 2415297 Review. No abstract available.
-
Role of cytokines in T and B cell mediated immunity.Concepts Immunopathol. 1986;3:74-108. Concepts Immunopathol. 1986. PMID: 3297329 Review. No abstract available.
Cited by
-
Antigen-independent activation of cytotoxic T cells by lymphokines.Immunology. 1988 May;64(1):121-8. Immunology. 1988. PMID: 3133307 Free PMC article.
-
Suppressor T cell growth and differentiation. Identification of a cofactor required for suppressor T cell function and distinct from interleukin 2.J Exp Med. 1984 May 1;159(5):1473-90. doi: 10.1084/jem.159.5.1473. J Exp Med. 1984. PMID: 6201587 Free PMC article.
-
The role of WNT10B in physiology and disease: A 10-year update.Front Cell Dev Biol. 2023 Feb 6;11:1120365. doi: 10.3389/fcell.2023.1120365. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 36814601 Free PMC article. Review.
-
Xenogeneic antiserum to soluble products from activated lymphoid cells inhibits interleukin 1-mediated functions in the helper pathway of cytolytic-effector-cell differentiation.Proc Natl Acad Sci U S A. 1985 Mar;82(5):1513-7. doi: 10.1073/pnas.82.5.1513. Proc Natl Acad Sci U S A. 1985. PMID: 3156379 Free PMC article.
-
Characterization of soluble factors that induce the cytolytic activity and the expression of T cell growth factor receptors of a T cell hybrid.J Exp Med. 1984 Aug 1;160(2):584-99. doi: 10.1084/jem.160.2.584. J Exp Med. 1984. PMID: 6236274 Free PMC article.